CEO`s Statement to Shareholders
02 Feb 2026 //
PHARMIWEB
Vaximm AG Revises Term Sheet to Shorten BCM Europe Exclusivity
02 Dec 2025 //
PR NEWSWIRE
Vaximm AG Enters Term With BCM Europe for VXM01 License
21 Nov 2025 //
PR NEWSWIRE
02 Feb 2026 //
PHARMIWEB
02 Dec 2025 //
PR NEWSWIRE
21 Nov 2025 //
PR NEWSWIRE
Market Place
Sourcing Support